1-6 of 6
Shufeng Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genetic alteration of class I HLA in cutaneous T-cell lymphoma

Alexa C Kwang, George E Duran, Sebastian Fernandez-Pol, Safa Najidh, Shufeng Li, Armando N Bastidas Torres, Erica B Wang, Melba Herrera, Tarek I Bandali, David M Kurtz, Youn H Kim, Michael S Khodadoust
Journal: Blood
Blood blood.2024024817.
https://doi.org/10.1182/blood.2024024817
Published: 2024
Includes: Supplemental data
Journal Articles

Clinical Characteristics, Treatment Patterns, and Outcomes of Cytotoxic Cutaneous T-Cell Lymphomas

Eric Mou, Sebastian Fernandez-Pol, Shufeng Li, Youn H. Kim, Michael S. Khodadoust
Journal: Blood
Blood (2022) 140 (Supplement 1): 6552–6553.
https://doi.org/10.1182/blood-2022-158610
Published: 2022
Journal Articles

Durable Responses with Pembrolizumab in Relapsed/Refractory Mycosis Fungoides and Sézary Syndrome: Final Results from a Phase 2 Multicenter Study

Michael S Khodadoust, MD PhD, Alain Rook, MD, Pierluigi Porcu, MD, Francine M. Foss, MD, Alison J. Moskowitz, MD, Andrei R. Shustov, MD, Satish Shanbhag, MD, Lubomir Sokol, MD PhD, Steven P Fling, PhD, Shufeng Li, MS, Asa Davis, PhD, Sophia Fong, BS, Jinah Kim, MD PhD, Yi Yang, Jennifer H Yearley, PhD DVM, Priyanka B Subrahmanyam, PhD, Holden T. Maecker, PhD, Yelena Budovskaya, PhD, Biswajit Das, PhD, Rajesh Patidar, PhD, Vivekananda Datta, MD PhD, Chris Karlovich, PhD, Steven M. Horwitz, MD, Elad Sharon, MD MPH, Holbrook Kohrt, MD PhD, Martin A Cheever, MD, Youn H. Kim, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2896.
https://doi.org/10.1182/blood-2018-99-117244
Published: 2018
Journal Articles

Pembrolizumab for Treatment of Relapsed/Refractory Mycosis Fungoides and Sezary Syndrome: Clinical Efficacy in a Citn Multicenter Phase 2 Study

Michael Khodadoust, MD PhD, Alain H. Rook, MD, Pierluigi Porcu, MD, Francine M. Foss, MD, Alison J. Moskowitz, MD, Andrei R Shustov, MD, Satish Shanbhag, MBBS, MPH, Lubomir Sokol, MD PhD, Richard Shine, PharmD, Steven P Fling, PhD, Shufeng Li, MS, Ziba Rabhar, Jinah Kim, MD PhD, Yi Yang, Jennifer Yearley, DVM, PhD, Elliot Keith Chartash, MD, Steven M. Townson, PhD, Priyanka B Subrahmanyam, PhD, Holden Maecker, PhD, Ash A. Alizadeh, MD PhD, Julia Dai, MD, Steven M Horwitz, MD, Elad Sharon, MD MPH, Holbrook Kohrt, MD, Martin A Cheever, MD, Youn Kim, MD
Journal: Blood
Blood (2016) 128 (22): 181.
https://doi.org/10.1182/blood.V128.22.181.181
Published: 2016
Journal Articles

Risk of Non-Melanoma Skin Cancer Following Hematopoietic Cell Transplantation and Voriconazole-Associated Risk

Lawrence F. Kuklinski, BA, Shufeng Li, MS, Margaret R. Karagas, PhD, Bernice Y. Kwong, MD, Wen-Kai Weng, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2249.
https://doi.org/10.1182/blood.V128.22.2249.2249
Published: 2016
Journal Articles

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides or Sezary Syndrome: Final Results Show Significant Clinical Activity and Suggest Correlation with CD30 Expression

Youn H. Kim, MD, Mahkam Tavallaee, MD MPH, Sima Rozati, MD, Uma Sundram, MD PhD, Katrin Salva, MD, Gary S. Wood, MD, Shufeng Li, MS, Michael Krathen, MD, Seema Nagpal, MD, Sunil Reddy, MD, Randall Armstrong, Richard T. Hoppe, MD, Melissa Pulitzer, MD, Ranjana H Advani, MD, Steven M. Horwitz, MD
Journal: Blood
Blood (2014) 124 (21): 804.
https://doi.org/10.1182/blood.V124.21.804.804
Published: 2014